ArticleSignal transduction and targeted therapy2025

Loss of the aryl hydrocarbon receptor promotes cancer cell resistance to BRAFV600E targeted therapies.

Mourad Zerfaoui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.